Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
61 /100
HIGH RISK
Score updated Oct 13, 2026

ASBP — Aspire Biopharma Holdings, Inc. Dilution Risk Tracker

Track ASBP dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track ASBP — Get alerts when the score changes →

As of October 13, 2026, Aspire Biopharma Holdings, Inc. (ASBP) has a DilutionWatch DilutionScore of 61/100, rated HIGH dilution risk. Aspire Biopharma Holdings, Inc. has a market capitalization of $10.91M, 1.40M shares outstanding, 10 institutional holders tracked. Stored dilution-related fields include shelf registration capacity of $20.00M.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
90
💰 Cash Runway
25
📊 Float Risk
27
⚠️ Warrant Exposure
40
🔄 Convertible Debt
85

Dilution Forecast

⛈️
Warning
High probability of dilution event
model est. 39%
🔁 Convertible Conversion model 60%
• Major convertible overhang: 88% potential dilution
• Convertible risk score very high (85/100)
💰 Capital Raise model 20%
• Active shelf registration ($20M, 183% of market cap)
🔄 Reverse Split model est. 15%
• 52-week low $0.11 has breached $1
🔔 Track ASBP — Get forecast alerts →

Market Data

Market Cap$10.91M
Shares Outstanding1.40M
Float1.20M
Cash$12.17M
Debt$1.50M
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore61/100DilutionWatch score record
Shares Outstanding1.40MVerified float table or market cache
Public Float1.20MVerified float table or market cache
Market Cap$10.91MMarket data cache
Cash Runway20.2 monthsDilutionWatch score inputs
Shelf Capacity$20.00MSEC-derived dilution fields
ATM CapacityNone in current score inputsSEC-derived dilution fields
Outstanding WarrantsNone in current score inputsSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 7.

Recent SEC source mix: 8-K 1, SC 13G 2, SC 13G/A 2, XBRL 2.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

10 institutional holders · 12.5K shares
#1 UBS Group AG 6.4K shares
#2 Morgan Stanley 2.6K shares
#3 Geode Capital Management, LLC 1.4K shares
+ 7 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest13.6K
Days to Cover1.0
% of Float1.1%
FINRA data as of Sep 30, 2026

Recent SEC Activity

xbrl XBRL CONVERTIBLE 2026-04-08
xbrl XBRL WARRANT 2025-11-14
SC 13G/A BENEFICIAL OWNERSHIP 2026-08-14
8-K 8K EVENT 2026-08-10
SC 13G BENEFICIAL OWNERSHIP 2026-08-10
Full SEC filing analysis available with free account →

Recent News

Factual ASBP Dilution Snapshot

Aspire Biopharma Holdings, Inc. (ASBP) has a DilutionScore of 61/100, rated High dilution risk. Score date: October 13, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

ASBP's DilutionScore is currently 61/100 (High risk), with 4 score changes tracked over 89 days. The score deteriorated from 69/100 (High risk).

Period Score Risk Level Duration
Oct 01 – Oct 13, 202661/100HIGH13 days
Sep 21 – Sep 30, 202669/100HIGH10 days
Aug 22 – Sep 20, 202676/100CRITICAL30 days
Aug 14 – Aug 21, 202667/100HIGH7 days
Jul 16 – Aug 13, 202688/100CRITICAL29 days

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Share Dilution History

ASBP shares outstanding have decreased 75.9% from 5.02M (Apr 2026) to 1.21M (May 2026). Each increase represents potential dilution to existing shareholders.

Date Shares Outstanding Public Float Change
May 18, 20261.21M1.20M▲ 673.41%
May 17, 20261.21M155.3K▲ 6.12%
May 04, 20265.02M4.39M▲ 0.67%
Apr 01, 20265.02M4.36M▲ 86.98%

Share counts sourced from verified regulatory filings. Increases indicate dilution events.

Track ASBP Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment ASBP files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking ASBP — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — HIGH Risk

Other HIGH dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,490+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for ASBP
ASBP FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.